Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.24 - $4.15 $13,177 - $24,414
-5,883 Reduced 34.85%
10,999 $30,000
Q4 2023

Feb 14, 2024

SELL
$1.39 - $2.46 $3,837 - $6,792
-2,761 Reduced 14.06%
16,882 $41,000
Q3 2023

Nov 14, 2023

SELL
$1.9 - $3.16 $68,899 - $114,591
-36,263 Reduced 64.86%
19,643 $39,000
Q2 2023

Aug 14, 2023

BUY
$2.36 - $3.59 $131,938 - $200,702
55,906 New
55,906 $164,000
Q4 2022

Feb 14, 2023

BUY
$2.76 - $3.71 $11,012 - $14,802
3,990 Added 13.07%
34,514 $109,000
Q3 2022

Nov 14, 2022

SELL
$2.93 - $3.96 $27,987 - $37,825
-9,552 Reduced 23.83%
30,524 $91,000
Q3 2022

Nov 14, 2022

SELL
$2.93 - $3.96 $27,987 - $37,825
-9,552 Reduced 23.83%
30,524 $91,000
Q2 2022

Aug 15, 2022

BUY
$2.74 - $13.43 $51,725 - $253,531
18,878 Added 89.06%
40,076 $122,000
Q1 2022

May 16, 2022

SELL
$8.96 - $13.51 $104,348 - $157,337
-11,646 Reduced 35.46%
21,198 $286,000
Q4 2021

Feb 14, 2022

SELL
$9.17 - $16.39 $34,139 - $61,019
-3,723 Reduced 10.18%
32,844 $428,000
Q3 2021

Nov 15, 2021

BUY
$9.15 - $11.09 $206,424 - $250,190
22,560 Added 161.06%
36,567 $343,000
Q2 2021

Aug 16, 2021

BUY
$10.24 - $20.87 $112,363 - $229,006
10,973 Added 361.67%
14,007 $143,000
Q1 2021

May 17, 2021

BUY
$16.9 - $29.77 $51,274 - $90,322
3,034 New
3,034 $56,000

Others Institutions Holding ATHA

About Athira Pharma, Inc.


  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $24.2M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.